Table 3. Comparison between Group P and Group C.
*P<0.05. Group P, cases of previous fractures in adjacent vertebral bodies; Group C, cases of no previous adjacent vertebral body fractures; BMI, body mass index; YAM, young adult mean; AVF, adjacent vertebral fracture
| Variable | Group P (n=32) | Group C (n=101) | p-value |
| Age | 79.4±6.5 | 77.1±5.5 | 0.134 |
| Sex (Man/Female) | 8/24 | 21/80 | 0.628 |
| BMI (kg/m2) | 22.1±1.9 | 23.1±3.2 | 0.196 |
| YAM (%) | 62.3±10.7 | 72.0±7.5 | <0.001* |
| Number of previous fractures | 2.3±1.4 | 0.5±0.7 | <0.001* |
| AVF | 10 (31.3%) | 24 (23.8%) | 0.486 |
| Steroid | 2 (6.0%) | 4 (4.0%) | 0.630 |
| parathyroid hormone preparations | 5 (15.2%) | 28 (28%) | 0.361 |
| Treatment for osteoporosis | 11 (30.2%) | 45 (44.6%) | 0.542 |
| Local kyphosis (°) | 0.7±7.6 | 4.3±8.8 | 0.120 |
| Fracture level (ThoracolumbarT11-L2/Thoracic, Lumbar) | 25/7 | 77/24 | 0.813 |